P.A.A. is used for theaffected areas P unit p.c Pg. Microgram p.m P.o. oral pr. Aur. Ear Prim. vic.no2 dose double P.R.N. when necessary pr Pr. Nar P.T.C. after skin test Q. 6h. Every 6 hours q. 2d.Once every two days Q.d. every day q.h Q.I.D. four times...
Therapeutics and clinical risk management Volume: 2 ISSN: 1176-6336 ISO Abbreviation: Ther Clin Risk Manag Publication Date: 2006 Decranging from 60?750 mg/m 2 once daily or as a repeated dose for up Cytogenetic responsesin high-risk myelodysplastic syndrome following low-dose treatment with the...
is used for the affected areas P unit p.c Pg. Microgram p.m P.o. oral pr. Aur. Ear Prim. vic.no2 dose double P.R.N. when necessary pr Pr. Nar P.T.C. after skin test Q. 6h. Every 6 hours q. 2d. Once every two days Q.d. every day q.h Q.I.D. four times a day...
An oral administration was conducted once daily continuing for 6 weeks. Once a week, the body weight and systolic blood pressure (SBP) of the rats were measured. To measure SBP, each rat was first kept at 37°C for 10 min, and then SBP of each rat was determined by the tail-...